An open-label, multicentre safety study of vemurafenib in patients with BRAFV600-mutant metastatic melanoma: final analysis and a validated prognostic scoring system
scientific article published on 20 December 2018
Author/s
author: Bart Neyns, Claus Garbe, Paul Lorigan, Piotr Rutkowski, Paolo Antonio Ascierto, James Larkin, Michael P. Brown, Helen Gogas, Mario Mandala, Paola Queirolo, Vanna Chiarion Sileni, Michele Del Vecchio, Geke A P Hospers, G Wilson Miller, Martina Makrutzki, Marta Nyakas, Ana Arance, Jacob Schachter, Christian U Blank
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.